Summary
A longitudinal study of intra and extrahepatic bile duct injuries was performed in an animal model of secondary sclerosing cholangitis induced by formalin injection into the common bile duct. Lymphocytic infiltration inside and around the bile ducts occurred seven days after injection. The disease later evolved to a fibrous cholangitis of the small bile ducts. Septal intrahepatic and extrahepatic bile duct involvement became evident three months after formalin injection. The ductular proliferation led to a progressive biliary cirrhosis with portal to portal fibrous septa. After formalin injection, bile duct cells expressed the Ia antigen in the cytoplasm and/or on the membrane of bile duct cells. The intensity of staining did not correlate with the duration or severity of the disease. Lymphocytes infiltrating into and around the bile duct were mainly T-cells. This study suggests that a local cell-mediated immune response to the injection of a toxic agent induces pathological features similar to those of sclerosing cholangitis in man.
Similar content being viewed by others
References
Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazo GF (1987) Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis. Relevance to pathogenesis. Lancet II:1009–1012
Barbatis C, Grases P, Shepherd HA, Chapman RW, Trowell J, Jewell DPJ, McGee JO (1985) Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis. J Clin Pathol 38:778–783
Blackstone MO, Nemchausky BA (1978) Cholangiographic abnormalities in ulcerative colitis associated pericholangitis which resemble sclerosing cholangitis. Am J Dig Dis 23:579–585
Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples C, Ludwig J (1983) Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 3:150–154
Bottazo F, Dean BM, McNally JM, McKay EH, Swifft PGF, Gamble DR (1985) In situ characterization of auto-immune phenomena and expression of HLA molecules in the pancreas in diabetes insulitis. N Eng J Med 313:353–360
Cerf-Bensussan N, Guaroni A, Kurnick J, Bann A (1985) Intra-epithelial lymphocytes module Ia expression by intestinal epithelial cells. J Immunol 132:2244–2251
Chapman WG, Marborgh BA, Rhodes J, Summerfield JA, Dick R, Scheuer PJ, Sherlock S (1980) Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 21:870–877
Chapman RW (1985) Primary sclerosing cholangitis. J Hepatol 1:179–186
Chapman RW, Kelly PMA, Heryet A, Jewell DP, Fleming KA (1988) Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29:422–427
Hanafusa T, Pujol-Barrel R, Chiovato R, Russel RCG, Domiach D, Bottazo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves disease: relevance for auto-immunity. Lancet II:1111–1115
Hsu SM, Raine L, Fanger H (1981) Use of Avidin-Biotin-Peroxiase complex (ABC) in immuno-peroxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedure. J Histochem Cytochem 59:577–580
Review by an international group (1983) Histopathology of the intrahepatic biliary tree. Liver 3:161–175
Kemeny MM, Battinflora H, Blayney DW (1985) Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 202:240–252
Larusso NF, Wiesner RH, Ludwig J, McCarty RL (1984) Primary sclerosing cholangitis. N Eng J Med 310:899–903
Lindor KD, Wiesner RH, LaRusso NF, Homburger HA (1987) Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 7:884–888
Ludwig J, Barham S, Larusso N, Elveback L, Wiesner R, Mac Call J (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 6:632–640
Ludwig J, Czaja A, Dickson E, Larusso N, Wiesner R (1984) Manifestations of non suppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 4:105–116
Ludwig J, Mac Carty R, Larusso N, Krom R, Wiesner R (1986) Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology 6:560–568
McFarlane IG, Wojcicka BM, Tsantoulas DC, Portmann BC, Eddlestone AL, Williams R (1979) Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology 76:1333–1340
Marymont JV, Dakhil SR, Travers H, Housholer DF (1985) Chemical cholecystitis associated with hepatic arterial chemotherapy delivered by a permanently implanted pump. Hum Pathol 16:986–990
Mistilis SP (1965) Pericholangitis and ulcerative colitis. I. Pathology, etiology and pathogenesis. Ann Intern Med 63:1–16
Nakanuma Y, Hirai N, Kono N, Ohta G (1986) Histological and ultrastructural examination of the intrahepatic biliary tree in primary sclerosing cholangitis. Liver 6:317–325
Shea WJ, Demas BE, Goldberg HI, Hohn DC, Ferrel LD, Kerlan RK (1986) Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologig correlation. AJR 146:717–721
Van Den Oord JJ, Sciot R, Desmet VJ (1986) Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 3:310–317
Wee A, Ludwig J (1985) Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 102:580–587
Whiteside TL, Lasky S, Si L, Vanthiel DL (1985) Immunologic analysis of mopnonuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 5:468–474
Wiesner RH, Larusso NF (1980) Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79:200–206
Author information
Authors and Affiliations
Additional information
This study was supported in part by a grant from the Research Council of the Faculté de Médecine, Université de Paris-Sud, and the Faculté de Médecine, Paris VI
Rights and permissions
About this article
Cite this article
Bedossa, P., Houry, S., Bacci, J. et al. A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis*. Vichows Archiv A Pathol Anat 414, 165–171 (1989). https://doi.org/10.1007/BF00718596
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00718596